FDA requires antibiotic resistance labeling

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF NURSING | 2003年 / 103卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：EE5 / EE5
页数：1
相关论文
共 50 条
  • [1] FDA devises plan on antibiotic resistance
    不详
    CHEMICAL & ENGINEERING NEWS, 2001, 79 (01) : 17 - 17
  • [2] Drug labeling: FDA requires new label for antibiotics to prevent overuse
    Tiwary, D
    JOURNAL OF LAW MEDICINE & ETHICS, 2003, 31 (03): : 458 - 460
  • [3] FDA requires labeling updates for prescription stimulants to improve safe use
    不详
    NURSE PRACTITIONER, 2023, 48 (08): : 48 - 48
  • [4] FDA Requires Black Box Warnings on Labeling for Botulinum Toxin Products
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (22): : 2316 - 2316
  • [5] Cubist highlights FDA's antibiotic resistance
    Fletcher, L
    NATURE BIOTECHNOLOGY, 2002, 20 (03) : 206 - 207
  • [6] Cubist highlights FDA's antibiotic resistance
    Liz Fletcher
    Nature Biotechnology, 2002, 20 : 206 - 207
  • [7] FDA addresses use of antibiotic resistance marker genes
    不详
    AUSTRALASIAN BIOTECHNOLOGY, 1998, 8 (05) : 264 - 264
  • [8] Antibiotic Allergy De-Labeling: A Pathway against Antibiotic Resistance
    Dona, Inmaculada
    Labella, Marina
    Bogas, Gador
    de Santa Maria, Rocio Saenz
    Salas, Maria
    Ariza, Adriana
    Jose Torres, Maria
    ANTIBIOTICS-BASEL, 2022, 11 (08):
  • [9] Antibiotic resistance: A complex problem that requires joint efforts
    Reutz, Marthe Helene Sandli
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2025, 145 (02)
  • [10] Addressing Antibiotic Resistance Requires Robust International Accountability Mechanisms
    Hoffman, Steven J.
    Ottersen, Trygve
    JOURNAL OF LAW MEDICINE & ETHICS, 2015, 43 : 53 - 64
12345